Please assess the completion status of the following clinical trial:

Trial Title: Amlodipine And Olmesartan Medoxomil In Hypertensive Filipino Patients

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: OTHER
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Filipino hypertensive subjects ages 18-65 years old whether naive or currently taking any other anti-hypertensive or those on monotherapy using CCBs or ARBs whom they want to shift on a fixed dose combination drug~Exclusion Criteria:~* Patients with contraindications to any of the component of the fixed drug (amlodipine or olmesartan medoxomil) or with malignant or secondary hypertension

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Filipino Hypertensive patients (Type: None): Male and Female, 18 to 65 year old Filipino hypertensive patients prescribed by their doctors with Normetec

Based on this trial design, predict the completion outcome and termination type (if applicable).